The American Association of Retired People, one of the USA's most influential political lobbying groups, has announced the launch of its 2007 legislative agenda. The list of proposals includes support for direct negotiations between the federal government and drugmakers over drug prices, support for generic biotechnology drugs, expanded Medicaid and SCHIP coverage (Marketletters passim).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze